| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 03/26/2009 | WO2009039414A2 Methods and compositions for detection of ehrlichia chaffeensis (vlpt) |
| 03/26/2009 | WO2009039413A2 Methods and compositions for detection of ehrlichia chaffeensis (p120) |
| 03/26/2009 | WO2009039363A2 Neuromyelitis optica autoantibodies as a marker for neoplasia |
| 03/26/2009 | WO2009039341A2 Neoepitope detection of disease using protein arrays |
| 03/26/2009 | WO2009039286A2 Frameless multiplexed microarrays |
| 03/26/2009 | WO2009039239A2 Lateral flow assay using centrifugal force |
| 03/26/2009 | WO2009039190A1 Cancer risk biomarker |
| 03/26/2009 | WO2009039170A2 Integrated protein chip assay |
| 03/26/2009 | WO2009039152A1 Detection of h. pylori utilizing unlabeled urea |
| 03/26/2009 | WO2009039136A2 Self-actuating signal producing detection devices and methods |
| 03/26/2009 | WO2009039078A1 Assessing congestive heart risk in patients treated or potentially to be treated with a peroxisome-proliferator-activator-receptor-gamma agonist or a thiazolidinedione |
| 03/26/2009 | WO2009039023A2 Detection of saliva proteins modulated secondary to ductal carcinoma in situ of the breast |
| 03/26/2009 | WO2009039004A1 A high throughput test method for evaluation of biocides against anaerobic microorganisms |
| 03/26/2009 | WO2009038798A1 Assay reader insert and method of maintaining a reader |
| 03/26/2009 | WO2009038742A2 Method for estimating risk of acute kidney injury |
| 03/26/2009 | WO2009038689A2 Compositions and methods for diagnosis and treatment of type 2 diabetes |
| 03/26/2009 | WO2009038646A1 Inductively charged vapor-emitting device |
| 03/26/2009 | WO2009038536A1 A device, system and method for washing and isolating magnetic particles in a continous fluid flow |
| 03/26/2009 | WO2009038104A1 Method for production of solid phase surface having low binding property |
| 03/26/2009 | WO2009037950A1 TRANSGENIC NON-HUMAN MAMMAL CAPABLE OF CONDITIONALLY EXPRESSING HUMAN K-ras MUTANT (K-rasV12) GENE, AND USE THEREOF |
| 03/26/2009 | WO2009037919A1 Cartridge and test piece measurement apparatus |
| 03/26/2009 | WO2009037857A1 Diagnostic agent and therapeutic agent for lung cancer, prostate cancer, breast cancer, ovarian cancer or melanoma |
| 03/26/2009 | WO2009037840A1 Method for measuring substrate concentration and device for the same |
| 03/26/2009 | WO2009037785A1 Method of examining instrument for analyzing body fluid and instrument for analyzing body fluid |
| 03/26/2009 | WO2009037784A1 Analytical instrument for body fluid component |
| 03/26/2009 | WO2009037636A1 Sensor with high frequency ac magnetic field |
| 03/26/2009 | WO2009037572A2 Biomarker combinations for colorectal cancer |
| 03/26/2009 | WO2009037481A1 Methods for diagnosing and treating dementia |
| 03/26/2009 | WO2009037454A2 Cancer marker and therapeutic target |
| 03/26/2009 | WO2009037436A1 Beverage monitor |
| 03/26/2009 | WO2009037402A2 Hpiv-2 variants and medical applications thereof |
| 03/26/2009 | WO2009037390A2 Use of the protein em6 as a performance marker for germination of seed lots and applications thereof |
| 03/26/2009 | WO2009037361A1 Microfluidic device and method for fluid clotting time determination |
| 03/26/2009 | WO2009037289A1 Gas sensor |
| 03/26/2009 | WO2009037089A1 Fuel system for a floating unit, and method for the operation thereof |
| 03/26/2009 | WO2009036968A1 Detection of tumor stem cells and tumor cells in epithelial-mesenchymal transition in body fluids of cancer patients |
| 03/26/2009 | WO2009036967A1 Solid phase cell isolation and/or enrichment method |
| 03/26/2009 | WO2009036931A1 Device and method for the regeneration of biosensors |
| 03/26/2009 | WO2009036885A1 Ed-b fibronectin as stratification marker for anti-tumor drugs |
| 03/26/2009 | WO2009036768A2 Diagnosing potential weight gain in a subject |
| 03/26/2009 | WO2009036578A1 Method and apparatus for the non-destructive measurement of the compressive strength of a solid |
| 03/26/2009 | WO2009036521A1 A method for identifying antigen-specific regulatory t cells |
| 03/26/2009 | WO2009021150A3 Platelet derived growth factor receptor supports cytomegalovirus infectivity |
| 03/26/2009 | WO2009020479A3 Device and methods for detection of airborne agents |
| 03/26/2009 | WO2009014863A9 Asc and pyrin-asc pyroptosomes and uses thereof |
| 03/26/2009 | WO2009014809A3 Biological analysis methods, biological analysis devices, and articles of manufacture |
| 03/26/2009 | WO2009013254A9 A novel population of hepatocytes derived via definitive endoderm (de-hep) from human blastocysts stem cells |
| 03/26/2009 | WO2009012340A3 Microfluidic devices, methods and systems for detecting target molecules |
| 03/26/2009 | WO2009009188A3 Uses of water-dispersible silica nanoparticles for attaching biomolecules |
| 03/26/2009 | WO2009007463A8 Ultrasound elution of biological ligands |
| 03/26/2009 | WO2009004189A3 Method for measuring the plasmine activity of microparticles present in a sample of a biological fluid and use thereof |
| 03/26/2009 | WO2009001229A3 Interactive garment printing for enhanced functionality of absorbent articles |
| 03/26/2009 | WO2009000920A9 Device and method for detecting a substance by means of particle plasmon resonance (ppr) or particle-mediated fluorescence based on cell surface polarizations |
| 03/26/2009 | WO2008157697A3 Copolymer assay |
| 03/26/2009 | WO2008157528A3 System and method for producing diesel exhaust for testing diesel engine aftertreatment devices |
| 03/26/2009 | WO2008154432A3 Crystalline topoisomerase/dna complexes |
| 03/26/2009 | WO2008145701A9 Method for predicting the outcome of a critically ill patient |
| 03/26/2009 | WO2008127376A3 Biological cell sorting and characterization using aerosol mass spectrometry |
| 03/26/2009 | WO2008121437A3 Trophinin-binding peptides and uses thereof |
| 03/26/2009 | WO2008118148A3 Adiponectin for the treatment and diagnosis of albuminuria |
| 03/26/2009 | WO2008117094A3 A modified petterson olfactometer |
| 03/26/2009 | WO2008112008A3 Sensor proteins and assay methods |
| 03/26/2009 | WO2008104804A3 Proteins |
| 03/26/2009 | WO2008021419A3 Nucleic acid quantitation from tissue slides |
| 03/26/2009 | WO2008019186A3 Blood monocyte cd163 expression as a biomarker in hiv-1 infection and neuroaids |
| 03/26/2009 | WO2008010101A8 Antagonist antibody against epha2 for the treatment of cancer |
| 03/26/2009 | WO2007070275A3 A calibrator for fluorosensor |
| 03/26/2009 | WO2006113050A4 Reagents for the detection of protein phosphorylation in carcinoma signaling pathways |
| 03/26/2009 | WO2006033662A3 Methods and kits for detection of multiple pathogens |
| 03/26/2009 | WO2006025808A3 Cross reactive arrays of three-way junction sensors for steroid determination |
| 03/26/2009 | WO2005117969A3 Solution phase biopanning method using engineered decoy proteins |
| 03/26/2009 | WO2005072457A3 Humoral response to hip1 in cancer |
| 03/26/2009 | WO2005067651A3 Surface plasmon resonance based nanoliter tear osmometer |
| 03/26/2009 | WO2005060725A3 Nucleic acid amplification methods |
| 03/26/2009 | WO2005048917A3 Use of epha4 and modulator or epha4 for diagnosis, treatment and prevention of cancer |
| 03/26/2009 | WO2005043120A3 Micro mechanical methods and systems for performing assays |
| 03/26/2009 | WO2005043111A3 Serum biomarkers for sars |
| 03/26/2009 | WO2005012551A3 Interaction of nmda receptor with protein tyrosine phosphatase |
| 03/26/2009 | WO2004104161A3 Methods and systems for identifying naturally occurring antisense transcripts and methods, kits and arrays utilizing same |
| 03/26/2009 | WO2004093804A3 Human polypeptides encoded by polynucleotides and methods of their use |
| 03/26/2009 | WO2004064612A3 Regulation of tgf-b signaling by tomoregulin |
| 03/26/2009 | US20090083867 Use of Antagonists of Cxcl13 or Cxcr5 for Treating Wounds of Fibrotic Diseases |
| 03/26/2009 | US20090083866 Transgenic rosa26-luciferase mice for bioluminescent imaging |
| 03/26/2009 | US20090083863 p300 transgenic animal |
| 03/26/2009 | US20090082975 Method of selecting an active oligonucleotide predictive model |
| 03/26/2009 | US20090082973 Analysis system for determining an analyte in a body fluid |
| 03/26/2009 | US20090082677 Exercise assisting devices |
| 03/26/2009 | US20090082654 Glucose Measuring Module And Insulin Pump Combination |
| 03/26/2009 | US20090082556 siRNA targeting TATA box binding protein (TBP)-associated factor (TAF1) |
| 03/26/2009 | US20090082551 Method, compositions and classification for tumor diagnostics and treatment |
| 03/26/2009 | US20090082410 Constitutively translocating cell line |
| 03/26/2009 | US20090082402 Methods of treating genitourinary disorders using inhibitors of soluble epoxide hydrolase |
| 03/26/2009 | US20090082304 Methods of Treating Hematological Malignancies with Nucleoside Analog Drugs |
| 03/26/2009 | US20090082303 Drug for preventing and treating atherosclerosis |
| 03/26/2009 | US20090082300 Modulation of transthyretin expression |
| 03/26/2009 | US20090082297 Compositions and Methods for Regulating Gene Expression |
| 03/26/2009 | US20090082296 Mycobacterial antigens expressed during latency |
| 03/26/2009 | US20090082294 Diagnosis, prevention and treatment of cancer |
| 03/26/2009 | US20090082265 Compositions and methods for treating diseases |
| 03/26/2009 | US20090082264 123 Human Secreted Proteins |